Beth Weinberg
General Counsel bei CARA THERAPEUTICS, INC.
Aktive Positionen von Beth Weinberg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CARA THERAPEUTICS, INC. | General Counsel | - | - |
Karriereverlauf von Beth Weinberg
Ehemalige bekannte Positionen von Beth Weinberg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ANGN BIOM | General Counsel | - | - |
| Metavant Sciences, Inc. | General Counsel | - | - |
Ausbildung von Beth Weinberg
| Bradley University | Undergraduate Degree |
| Butler University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| General Counsel | 3 |
| Undergraduate Degree | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CARA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Metavant Sciences, Inc. | |
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
- Börse
- Insiders
- Beth Weinberg
- Erfahrung
